3B Blackbio Dx Limited (NSE:3BBLACKBIO)
1,293.60
+17.70 (1.39%)
At close: Nov 9, 2026
| Market Cap | 11.06B -2.9% |
| Revenue (ttm) | 1.53B +54.3% |
| Net Income | 555.29M +13.0% |
| EPS | 65.19 +13.9% |
| Shares Out | n/a |
| PE Ratio | 19.84 |
| Forward PE | n/a |
| Dividend | 5.00 (0.39%) |
| Ex-Dividend Date | Sep 22, 2026 |
| Volume | 9,965 |
| Open | 1,301.50 |
| Previous Close | 1,275.90 |
| Day's Range | 1,266.00 - 1,314.00 |
| 52-Week Range | 1,085.00 - 1,740.00 |
| Beta | 0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |